Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects-Reference-Cited by-同舟云学术

Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects

Published:2021-03-15 Issue:5 Volume:95 Page:1535-1546
ISSN:0340-5761
Container-title:Archives of Toxicology
language:en
Short-container-title:Arch Toxicol

Author:

Rendic Slobodan P.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Toxicology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00204-021-03025-z.pdf

Reference77 articles.

1. Anselmi M, Buonfrate D, Guevara Espinoza A et al (2015) Mass Administration of ivermectin for the elimination of onchocerciasis significantly reduced and maintained low the prevalence of Strongyloides stercoralis in esmeraldas. Ecuador. PLoS Negl Trop Dis 9(11):e0004150. https://doi.org/10.1371/journal.pntd.0004150 (Published 2015 Nov 5)

2. Bapiro TE, Egnell AC, Hasler JA, Masimirembwa CM (2001) Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s. Drug Metab Dispos 29(1):30–35

3. Bircsak KM, Aleksunes LM (2015) Interaction of isoflavones with the BCRP/ABCG2 drug transporter. Curr Drug Metab 16(2):124–140. https://doi.org/10.2174/138920021602150713114921

4. Boatin BA, Richards FO Jr (2006) Control of onchocerciasis. Adv Parasitol 61:349–394. https://doi.org/10.1016/S0065-308X(05)61009-3

5. Bradley G, Juranka PF, Ling V (1988) Mechanism of multidrug resistance. Biochim Biophys Acta 948(1):87–128. https://doi.org/10.1016/0304-419x(88)90006-6

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Systemically Absorbed Drugs to Explore An In Vitro Bioequivalence Approach For Comparing Non-Systemically Absorbed Active Pharmaceutical Ingredients in Drug Products For Use in Dogs;Pharmaceutical Research;2024-09-09

2. Ivermectin-induced toxicity in HepG2 cells and the protective effect of tetrahydrocurcumin and vitamin C;Drug and Chemical Toxicology;2024-08-19

3. Efficacy of ivermectin and its metabolites against Plasmodium falciparum liver stages in primary human hepatocytes;Antimicrobial Agents and Chemotherapy;2024-08-07

4. An in‐depth analysis of COVID‐19 treatment: Present situation and prospects;Archiv der Pharmazie;2024-08-06

5. Metabolism, Disposition, Excretion, and Potential Transporter Inhibition of 7–16, an Improving 5-HT2A Receptor Antagonist and Inverse Agonist for Parkinson’s Disease;Molecules;2024-05-08